SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024651
Filing Date
2020-05-12
Accepted
2020-05-12 16:06:50
Documents
69
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vir-10q_20200331.htm   iXBRL 10-Q 2505122
2 EX-31.1 vir-ex311_8.htm EX-31.1 21001
3 EX-31.2 vir-ex312_7.htm EX-31.2 20890
4 EX-32.1 vir-ex321_6.htm EX-32.1 9676
  Complete submission text file 0001564590-20-024651.txt   8750357

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vir-20200331.xsd EX-101.SCH 71280
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vir-20200331_cal.xml EX-101.CAL 58579
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vir-20200331_def.xml EX-101.DEF 247424
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20200331_lab.xml EX-101.LAB 538423
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20200331_pre.xml EX-101.PRE 410282
45 EXTRACTED XBRL INSTANCE DOCUMENT vir-10q_20200331_htm.xml XML 1368891
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 20869127
SIC: 2836 Biological Products, (No Diagnostic Substances)